SYK
Stryker Corporation
NYSE · USHealthcareMedical - Devices
$319.14-0.23%
Price as of Jul 20, 2026
SYK financials
Stryker Corporation financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $25.1B | $22.6B | $20.5B | $18.4B |
| Cost of revenue | $9.1B | $8.6B | $8.0B | $7.4B |
| Gross profit | $16.1B | $14.0B | $12.5B | $11.0B |
| Operating expenses | $11.2B | $8.9B | $8.2B | $7.3B |
| Operating income | $4.9B | $5.1B | $4.3B | $3.7B |
| Net income | $3.2B | $3.0B | $3.2B | $2.4B |
| EBITDA | $6.3B | $4.9B | $5.1B | $4.0B |
| Basic EPS | $8.49 | $7.86 | $8.34 | $6.23 |
| Diluted EPS | $8.40 | $7.76 | $8.25 | $6.17 |
| Balance sheet | ||||
| Cash & equivalents | $4.0B | $3.7B | $3.0B | $1.8B |
| Total assets | $47.8B | $43.0B | $39.9B | $36.9B |
| Total liabilities | $25.4B | $22.3B | $21.3B | $20.3B |
| Stockholders’ equity | $22.4B | $20.6B | $18.6B | $16.6B |
| Total debt | $16.4B | $14.1B | $13.5B | $13.5B |
| Net debt | $12.3B | $10.5B | $10.5B | $11.7B |
| Cash flow | ||||
| Operating cash flow | $5.0B | $4.2B | $3.7B | $2.6B |
| Capital expenditure | -$761.0M | -$755.0M | -$575.0M | -$588.0M |
| Free cash flow | $4.3B | $3.5B | $3.1B | $2.0B |
| Dividends paid | -$1.3B | -$1.2B | -$1.1B | -$1.1B |
| Share repurchases | -$149.0M | -$195.0M | -$155.0M | -$122.0M |